Jpmorgan Chase & CO Ionis Pharmaceuticals Inc Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 415,919 shares of IONS stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
415,919
Previous 568,906 26.89%
Holding current value
$12.3 Million
Previous $22.8 Million 36.2%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$33.73 - $40.36 $5.16 Million - $6.17 Million
-152,987 Reduced 26.89%
415,919 $14.5 Million
Q3 2024

Dec 26, 2024
SELL
$40.06 - $51.86 $1.01 Million - $1.31 Million
-25,185 Reduced 4.24%
568,906 $22.8 Million
Q3 2024

Nov 08, 2024
SELL
$40.06 - $51.86 $1.01 Million - $1.31 Million
-25,185 Reduced 4.24%
568,906 $22.8 Million
Q2 2024

Dec 26, 2024
BUY
$36.45 - $47.7 $917,993 - $1.2 Million
25,185 Added 4.43%
594,091 $28.3 Million
Q2 2024

Aug 12, 2024
SELL
$36.45 - $47.7 $1.34 Million - $1.76 Million
-36,888 Reduced 5.85%
594,091 $28.3 Million
Q1 2024

Dec 26, 2024
BUY
$42.03 - $53.55 $2.61 Million - $3.32 Million
62,073 Added 10.91%
630,979 $27.4 Million
Q1 2024

May 10, 2024
SELL
$42.03 - $53.55 $13 Million - $16.6 Million
-310,053 Reduced 32.95%
630,979 $27.4 Million
Q4 2023

Dec 26, 2024
BUY
$43.39 - $51.63 $16.1 Million - $19.2 Million
372,126 Added 65.41%
941,032 $47.6 Million
Q4 2023

Feb 12, 2024
BUY
$43.39 - $51.63 $1.73 Million - $2.06 Million
39,975 Added 4.44%
941,032 $47.6 Million
Q3 2023

Nov 14, 2023
SELL
$38.5 - $47.13 $6.42 Million - $7.85 Million
-166,666 Reduced 15.61%
901,057 $40.9 Million
Q2 2023

Aug 11, 2023
BUY
$34.73 - $43.33 $358,691 - $447,512
10,328 Added 0.98%
1,067,723 $43.8 Million
Q1 2023

May 18, 2023
BUY
$33.58 - $41.2 $2.67 Million - $3.27 Million
79,417 Added 8.12%
1,057,395 $37.8 Million
Q1 2023

May 11, 2023
BUY
$33.58 - $41.2 $257,491 - $315,921
7,668 Added 0.79%
977,978 $35 Million
Q4 2022

Feb 13, 2023
BUY
$37.12 - $46.52 $1.54 Million - $1.93 Million
41,558 Added 4.47%
970,310 $36.6 Million
Q3 2022

Nov 14, 2022
SELL
$36.54 - $48.66 $4.05 Million - $5.39 Million
-110,818 Reduced 10.66%
928,752 $41.1 Million
Q2 2022

Aug 11, 2022
SELL
$31.71 - $43.0 $4.5 Million - $6.11 Million
-141,987 Reduced 12.02%
1,039,570 $38.5 Million
Q1 2022

May 11, 2022
SELL
$29.88 - $37.04 $2.6 Million - $3.23 Million
-87,095 Reduced 6.87%
1,181,557 $43.8 Million
Q4 2021

Feb 10, 2022
SELL
$25.61 - $35.1 $29.4 Million - $40.3 Million
-1,147,661 Reduced 47.5%
1,268,652 $38.6 Million
Q3 2021

Nov 12, 2021
BUY
$33.54 - $40.55 $81 Million - $98 Million
2,416,313 New
2,416,313 $81 Million

Others Institutions Holding IONS

# of Institutions
410
Shares Held
131M
Call Options Held
829K
Put Options Held
789K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.2B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email